Professor Seok Chaok: "AI Drug Development Hinges on Ideas and GPU Competition"
"Ability to Translate Medical Needs into Molecular Design Is Essential"
"Importance of Human and Medical Data Will Grow"
"In AI-driven drug development, competition at the molecular design level will hinge on ideas and computing resources."
Seok Chaok, Professor of Chemistry at Seoul National University and Co-CEO of Gallax, stated this during a media interview at the Fall Conference of the Korean Society for Biotechnology and Bioengineering, held at the Jeju International Convention Center (ICC) on October 2, 2026. Discussing AI-based drug development, he remarked, "For AI to advance to the stage where it can predict actual therapeutic effects in patients, securing medical and human biological data is crucial." While graphics processing units (GPUs) are currently a key element in the AI drug industry, there is a growing expectation that data itself will become increasingly important.
Seok Chaok, Professor of Chemistry at Seoul National University and Co-CEO of Galax. Photo by Jungyeon Park
View original imageProfessor Seok, who is an expert in protein structure modeling and AI-powered drug development, is also a member of the National Artificial Intelligence Strategy Committee. Addressing concerns about Korea's lack of capital and data volume in the global competition for AI-based drug discovery, he said, "At the molecular level, the data gap is not significant." He further explained, "Even Google DeepMind, which developed AlphaFold, used the same type of publicly available datasets as its competitors."
Professor Seok pointed out that the real shortfall for Korea lies not in molecular data, but in medical data at the system and human levels. He remarked, "When it comes to data on the system and individual level, Korea is absolutely lacking." However, he assessed that the current state of AI is not yet ready to utilize this type of data in a truly innovative way. "Establishing a nationwide system to collect and utilize such data is extremely important in order to move toward that stage," he suggested.
The next challenges in AI-based protein design, according to Professor Seok, are precise targeting and adapting to complex biological environments. Whereas traditional efforts concentrated on finding binding molecules for proteins with well-defined structures, future developments will need to distinguish targets situated in more flexible and complex contexts. "Simply improving the performance of AI models is not enough for such designs," he emphasized, "It requires the ability to translate the medical needs for treatment into molecular-level design specifications, to implement those specifications with AI, and to verify the results."
This is the motivation behind Professor Seok's direct involvement in drug development. Introducing Gallax, the AI-driven protein design company he founded, he said, "This is a company that builds the necessary expertise for drug development using an AI platform and then develops drugs based on that expertise." He explained that partnerships with big pharma and other collaborators are focused not on the competitiveness of the platform itself, but on creating therapies that would be difficult to develop using conventional methods.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Professor Seok also argued that, for AI to become a tool that benefits all of science and technology beyond drug development, government support approaches need to change. "It is not desirable for the government to designate just a specific field for support," he asserted, adding that researchers should be enabled to explore how AI could be leveraged in their respective areas of expertise.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.